|
Kleinert, S., P. Bartz-Bazzanella, C. von der Decken, et al. (2021).
"A Real-World Rheumatology Registry and Research Consortium: The
German RheumaDatenRhePort (RHADAR) Registry." J Med Internet Res
23(5): e28164.
|
|
Kleinert, S., P. Rapp, F. Schuch, M., et al. (2021). "Cognitive
Impairment in axial spondyloarthritis? [abstract]." Annals of the
Rheumatic Diseases 80(Suppl 1): 1274.
|
|
Kleinert S, Bartz-Bazzanella P, von der Decken C, et al., Chronic
Kidney Disease Is Underestimated in Patients with Rheumatoid Arthritis
– Real World Data Gathered from a Network of Rheumatologists
[abstract]. Arthritis Rheumatol. 2020; 72 (suppl 10).
|
|
|
Stefan Kleinert, Praxedis Rapp, Monika Ronneberger, Joerg Wendler,
Florian Schuch, Dealing with comorbidities in rheumatoid arthritis
with medical assistants. The patients’ opinion on assessment and
education by medical assistants during routine clinical practice. Ann
Rheum Dis, volume 78, supplement 2, year 2019, page A1448
|
|
Stefan Kleinert, Florian Schuch, Praxedis Rapp, Monika Ronneberger,
Joerg Wendler, Matthias Englbrecht, How many of your patients have
depressive symptoms? How to assess during routine clinical practice?,
Ann Rheum Dis, volume 78, supplement 2, year 2019, page A638
|
|
Englbrecht M, Alten R, Aringer M, Baerwald CG, Burkhardt H, Eby N, et
al. New insights into the prevalence of depressive symptoms and
depression in rheumatoid arthritis - Implications from the prospective
multicenter VADERA II study. PLoS One. 2019;14(5):e0217412.
|
|
Kleinert S. Komorbiditäten und Mortalität bei Patienten mit
entzündlichen Gelenkerkrankungen. Akt Rheumatol. 2018;43(02):156-60.
|
|
Breunig M*, Kleinert S* (*gemeinsame Erstautorschaft), Lehmann S et
al. Simple screening tools predict death and cardiovascular events in
patients with rheumatic disease. Scand J Rheumatol 2017: 1-8
|
|
Kleinert S, La Rosée P, Krüger K. Rheumatische Krankheitserscheinungen
bei hämatologischen Neoplasien. Zeitschrift für Rheumatologie 2017;
76: 38-45
|
|
Kleinert, S., M. Waldner, J. Wendler and V. Kunzmann.
"[Disease-Modifying Antirheumatic Drugs in Rheumatoid Arthritis
Patients with a History of Colorectal Cancer]." Z Rheumatol 75, no. 1
(2016): 41-6.
|
|
Kleinert, Stefan, Marx, Almuth, Faller, Hermann, Feuchtenberger,
Martin, Kneitz, Christian, Lehmann, Stefanie, Tony, Hans-Peter,
Angermann, Christiane, Ertl, Georg, Stefan Störk, Breunig, Margret;
Prevalence and Relevance of Depressive Symptoms in Patients with
Rheumatic Diseases; ACR 2015
|
|
Kleinert, Stefan, Marx, Almuth, Faller, Hermann, Feuchtenberger,
Martin, Kneitz, Christian, Lehmann, Stefanie, Tony, Hans-Peter,
Angermann, Christiane, Ertl, Georg, Stefan Störk, Breunig, Margret;
Prävalenz und Relevanz von depressiven Symptomen bei Patienten mit
entzündlich-rheumatischen Erkrankungen, DGRh 2015
|
|
Müller-Ladner, U., S. Kleinert, K. Krüger, B. Wittig and R. Hecker.
"Unique Profile of Cardiovascular Risk Factors in Rheumatoid Arthritis
High-Risk Populations with Insufficient Risk Control." Arthritis Rheum
66, no. Suppl 10 (2014): 469.
|
|
Haschka, J., M. Englbrecht, A. J. Hueber, B. Manger, A. Kleyer, M.
Reiser, S. Finzel, H. P. Tony, S. Kleinert, M. Feuchtenberger, M.
Fleck, K. Manger, W. Ochs, M. Schmitt-Haendle, J. Wendler, F. Schuch,
M. Ronneberger, H. M. Lorenz, H. Nuesslein, R. Alten, W. Demary, J.
Henes, G. Schett and J. Rech. "Relapse Rates in Patients with
Rheumatoid Arthritis in Stable Remission Tapering or Stopping
Antirheumatic Therapy: Interim Results from the Prospective Randomised
Controlled Retro Study." Ann Rheum Dis, (2015).
|
|
Kleinert, S., M. Breunig, H. Tony, M. et al. (2013). "Outcome In
Patients With Rheumatoid Disease: Simple Screening Tools Predict
Cardiovascular Events and Death." Arthritis Rheum 65(Suppl 10): 783
|
|
Kleinert S, Krueger K, Stork S. Atheroskleroserisiko durch
Inflammation bei rheumatoider Arthritis. Zeitschrift für
Rheumatologie. 2012 Dec; 71(10):850-858.
|
|
Kleinert S, Tony HP, Krueger K, et al. Screening for latent
tuberculosis infection: performance of tuberculin skin test and
interferon-gamma release assays under real-life conditions. Annals of
the Rheumatic Diseases. 2012 Nov; 71(11):1791-1795.
|
|
Kleinert, S.; Krueger, K., [Cardiovascular comorbidity and its risk
factors in rheumatoid arthritis]. Zeitschrift für Rheumatologie 2011,
70, (6), 464-72.
|
|
Kleinert S, Tony HP, Krause A, et al. Impact of patient and disease
characteristics on therapeutic success during adalimumab treatment of
patients with rheumatoid arthritis: data from a German
noninterventional observational study. Rheumatology international.
2012 Sep; 32(9):2759-2767.
|
|
Kleinert, S.; Kurzai, O.; Elias, J. et al., Comparison of two
interferon-gamma release assays and tuberculin skin test for detecting
latent tuberculosis in patients with immune-mediated inflammatory
diseases. Ann Rheum Dis 2010, 69, (4), 782-4.
|
|
Kleinert S, Feuchtenberger M, Tony HP. [Systemic lupus erythematosus.
A problem based approach]. Internist (Berl). 2010 Aug;
51(8):1013-1026.
|
|
Kleinert, S. et al. (Hg.), Der medizinische Blick auf Behinderung,
Königshausen und Neumann, Würzburg 1997
|
|
Höglinger, G., Kleinert, S. (Hg.), Hirntod und Organtransplantation,
de Gruyter, Berlin 1998
|
|
Kleinert S. [Data analysis in rheumatology practices : Possibilities,
limitations, and results]. Z Rheumatol. 2021;80(9):827-34.
|
|
Englbrecht M, Bartz-Bazzanella P, von der Decken C, Gauler G, Wurth P,
Aries P, et al. Prevalence of Depressive Symptoms in Patients With
Psoriatic Arthritis: Have Numbers Changed During the COVID-19
Pandemic? Front Med (Lausanne). 2021;8:748262.
|
|
Simon D, Tascilar K, Fagni F, Kronke G, Kleyer A, Meder C, et al.
SARS-CoV-2 vaccination responses in untreated, conventionally treated
and anticytokine-treated patients with immune-mediated inflammatory
diseases. Ann Rheum Dis. 2021.
|
|
Knitza J, Mohn J, Bergmann C, Kampylafka E, Hagen M, Bohr D, et al.
Accuracy, patient-perceived usability, and acceptance of two symptom
checkers (Ada and Rheport) in rheumatology: interim results from a
randomized controlled crossover trial. Arthritis Res Ther.
2021;23(1):112.
|
|
Simon D, Tascilar K, Kronke G, Kleyer A, Zaiss MM, Heppt F, et al.
Patients with immune-mediated inflammatory diseases receiving cytokine
inhibitors have low prevalence of SARS-CoV-2 seroconversion. Nat
Commun. 2020;11(1):3774.
|
